Related Experiment Video
Updated: May 1, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
11.6K
Medication review practices in European countries
A Bulajeva1, L Labberton2, S Leikola3
1Division of Social Pharmacy, University of Helsinki, P.O. Box 56, 00014 Finland.
Research in Social & Administrative Pharmacy : RSAP
|March 26, 2014
Summary
Medication review procedures are increasingly common in Europe. However, comprehensive clinical reviews remain rare due to limited patient information access, highlighting a need for improved data sharing to enhance patient safety.
Area of Science:
- Pharmaceutical policy
- Healthcare services research
- Medication safety
Background:
- Medication review procedures aim to enhance rational and safe medication use globally.
- Previous assessments have not comprehensively compared the similarities, comprehensiveness, or effectiveness of these procedures across different countries.
Purpose of the Study:
- To explore and compare medication review practices across European countries.
- To assess the comprehensiveness and types of medication review procedures implemented in Europe.
Main Methods:
- An online survey was distributed to 32 European countries in May 2011.
- Informants were identified via the Pharmaceutical Group of the European Union and validated through the Pharmaceutical Care Network Europe.
- The survey evaluated medication review comprehensiveness based on settings, patient data access, patient involvement, documentation, physician collaboration, quality control, and training.
Main Results:
- 64% of responding European countries (25 out of 32) reported having at least one type of medication review procedure.
- Prescription (Type I) and adherence (Type II) medication reviews were most prevalent in community settings.
- Comprehensive Type III clinical medication reviews, requiring patient clinical information access, were infrequent, established in only 6 countries.
Conclusions:
- Medication review procedures are becoming widespread in European healthcare.
- Enhancing the comprehensiveness of clinical medication reviews necessitates improved access to patient clinical information for healthcare professionals.
- This inventory can facilitate international cooperation and benchmarking for medication review practice development.
Related Concept Videos
01:19Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
01:25Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
01:15Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
01:03Drug Control Governance: Regulatory Bodies and Their Impact
706
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
706
01:28Dosage Regimens: Designs and Approaches
600
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
600
01:24Dosage Regimen: Individualization
398
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
398